Dudediligence.

Haemonetics Corporation

HAENYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$345.5MSep ’24$348.5MDec ’24$330.6MMar ’25$321.4MJun ’25$327.3MSep ’25$339.0MDec ’25$346.4MMar ’26$339.4MJun ’26
Net income, by quarter
$33.8MSep ’24$37.5MDec ’24$58.0MMar ’25$34.0MJun ’25$38.7MSep ’25$44.7MDec ’25−$117.4MMar ’26$33.0MJun ’26
Fiscal years, by the month each ended
LineMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue$993.2M$1.17B$1.31B$1.36B$1.33B
Gross profit$505.5M$615.1M$691.5M$749.0M$787.6M
Operating income$80.8M$156.0M$164.9M$221.8M$156.7M
Net income$43.4M$115.4M$117.6M$167.7M$97,308
Operating cash flow$172.3M$273.1M$181.8M$181.7M$293.2M
Free cash flow$75.8M$81.7M$143.6M$142.4M$260.4M
Cash$259.5M$284.5M$178.8M$306.8M$245.4M
Debt$773.6M$765.9M$807.8M$1.22B$1.22B
Shares outstanding51.1M50.4M50.8M48.2M45.3M